Background: Type I and type IV-A choledochal cysts (CC) in Todani's classification are the most frequent types of CC. Unlike type I cyst, in which the dilatation is confined to the extrahepatic bile duct, type IV-A affects both extra and intrahepatic ducts.

Aim: To review our experience of complete cyst excision with Roux-en-Y hepaticojejunostomy for the treatment of type I and type IV-A CC in childhood, in order to better characterize these entities.

Material And Methods: Data was collected retrospectively from a cohort of children who underwent cyst resection for CC from 1989 to 2011 in our institution.

Results: Twelve patients were submitted to surgical excision of extrahepatic cyst and hepaticojejunostomy for treatment of type I (n = 6) and type IV-A (n = 6) cysts, with a complication rate of 25% (n = 3) and no mortality. Long term follow-up was available in 92% of patients, with a median of 10 years (2-22 years). Morbidities consisted of bile leak (2 patients) and late-onset cholestasis (1 patient); two of these required anastomotic revision. The results did not reveal any significant differences between the groups regarding postoperative outcomes (P > 0.05). Preoperative intrahepatic dilatation was found to permanently vanish in 83% of patients diagnosed with type IV-A cyst after operative repair.

Conclusions: Intrahepatic dilatation of type IV-A cyst in children did not adversely affect the postoperative outcome after conventional surgical repair. This operative approach was effective in the management of type I and type IV-A cysts.

Download full-text PDF

Source

Publication Analysis

Top Keywords

type iv-a
28
type type
16
type
12
choledochal cysts
8
extrahepatic cyst
8
cyst excision
8
excision roux-en-y
8
roux-en-y hepaticojejunostomy
8
hepaticojejunostomy treatment
8
treatment type
8

Similar Publications

Multi Targeted Activity of Cocculus hirsutus through Modulation of DPP-IV and PTP-1B Leading to Enhancement of Glucose Uptake and Attenuation of Lipid Accumulation.

Appl Biochem Biotechnol

January 2025

Tissue Culture and Drug Discovery Laboratory, Department of Biotechnology, Anna University, Chennai, 600 025, India.

Article Synopsis
  • Multi-targeted therapies are increasingly recognized for their effectiveness in treating complex diseases such as Type 2 diabetes and obesity, utilizing multiple mechanisms to enhance benefits while minimizing side effects.
  • The study investigates the potential of Cocculus hirsutus methanol extract (CME) and its hydromethanolic fraction (HMF), revealing significant inhibition of key enzymes related to glucose metabolism and insulin signaling, which indicates their potential in improving metabolic health.
  • HMF was particularly effective, showing improved glucose uptake, increased insulin sensitivity through GLUT4 expression, and reduced lipid accumulation by inhibiting adipogenesis regulators, marking its promise as a therapeutic option.
View Article and Find Full Text PDF

Directly anterior approach for total hip arthroplasty with an acetabular structural bone graft for developmental dysplasia of the hip (Crowe III and IV): a concise 5-year follow-up evaluation.

BMC Musculoskelet Disord

December 2024

Department of Orthopaedics, the First Affiliated Hospital of Bengbu Medical University, Osteoarthritis Diagnosis and Treatment Center in Anhui Province, Laboratory of Tissue and Transplant in Anhui Province, Bengbu Medical University, #287 Zhihuai Road, Bengbu City, Anhui Province, China.

Background: This study evaluated the results of total hip arthroplasty (THA) via the direct anterior approach (DAA) in the lateral decubitus position combined with acetabular reconstruction via a bulk autograft for patients with developmental dysplasia of the hip (Crowe III and IV).

Patients And Methods: A retrospective study was conducted to analyse 16 patients (16 hips) with Crowe type III and IV developmental dysplasia of the hip (DDH) who underwent THA from June 2016 to July 2021. We recorded and analysed variables such as age, sex, height, body mass index (BMI), length of surgical incision, duration of surgery, intraoperative blood loss, Harris hip score, visual analogue scale (VAS) score, lower limb length, and pelvic radiograph analysis.

View Article and Find Full Text PDF

Optimal biomechanical choice of implant placement in various pilon fracture types: a finite element study.

BMC Musculoskelet Disord

November 2024

Department of Orthopedics, General Hospital of Central Theater Command of PLA, (Wuhan General Hospital of Guangzhou Command, Previously), Hubei Province, NO. 627, Wuluo Road, Wuhan, 430030, P.R. China.

Article Synopsis
  • The study examines the impact of fracture displacement directions on stress distribution in both bones and implants for pilon fractures, a type of ankle injury.
  • Different fracture types were categorized and assessed under specific loading conditions, utilizing various plate placements and lag screws for treatment.
  • Results indicated significant differences in stress levels among the different fracture subtypes, leading to recommendations for optimal implant placement based on fracture type to improve surgical outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • - The study evaluates surgical outcomes in children with type IV-A choledochal cysts (CDC), focusing on postoperative complications like strictures and intrahepatic stones, which have previously been associated with a poor prognosis.
  • - Researchers analyzed 76 patients who underwent laparoscopic cyst excision and biliary reconstruction, categorizing them based on whether their intrahepatic duct dilatation normalized within a year post-surgery.
  • - Follow-up results showed a high normalization rate of intrahepatic duct size (73.7% of patients) after an average recovery time of 1.65 months, with few complications; however, factors such as biliary sludge and the duct's maximum diameter were found to influence recovery outcomes.
View Article and Find Full Text PDF

Inflammation induced by angiotensin II (Ang II) is a key event in the progression of numerous cardiovascular diseases. Astragaloside IV (AS-IV), a glycoside extracted from , has been shown to inhibit Ang II-induced inflammatory responses in vivo. However, the mechanisms underlying the beneficial effects are still unclear.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!